Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece ...

Tempus AI was targeted by a short seller last week. Since then, the company has made several announcements that have helped ...

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. (NASDAQ: TEM) resulting from allegations ...

Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor ...

智通财经APP获悉，周一，Tempus AI (TEM.US)大涨超12%，报62.09美元。消息面上，该公司推出Fuses计划，旨在变革治疗研究并建立最大的诊断平台，利用其新颖的基础模型。此外，该公司推出Xm，一种用于监测晚期癌症患者免疫疗法反应的检测方法。

周一，Tempus AI(TEM.US)大涨超12%，报62.09美元。消息面上，该公司推出Fuses计划，旨在变革治疗研究并建立最大的诊断平台，利用其新颖的基础模型。此外，该公司推出Xm，一种用于监测晚期癌症患者免疫疗法反应的检测方法。

Pomerantz LLP is investigating claims on behalf of investors of  Tempus AI, Inc. ("Tempus" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a ...

An independent safety board has endorsed the continuation of BioXcel Therapeutics, Inc.'s (NASDAQ: BTAI) pivotal Phase 3 SERENITY At-Home trial evaluating BXCL501 for agitation tied to bipolar ...

Tempus AI is a healthcare-oriented artificial intelligence company. Spruce Point Capital Management released a report ...

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 30, 2025 /PRNewswire/ -- The concept of AI in healthcare is no longer a novelty ...